Post-op Prednisone and Glucose Monitoring in TKA
Postoperative Prednisone Regimen in TKA and Its Effect on Continuous Glucose Levels
- Osteoarthritis
- Unicompartmental Knee Arthroplasty
- Total Hip Arthroplasty (THA)
At a glance
- Phase
- Phase 4
- Study type
- Interventional
- Sponsor
- Columbia University
- Enrolment target
- 104
- Started
- 22 June 2026
- Main results due
- December 2027
- Study sites
- 1
- Registry updated
- 24 September 2026
Can you take part?
- Aged 18 years and over.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion Criteria: * Undergoing Primary Unicompartmental Knee Arthroplasty or Total Hip Arthroplasty * Age 18 and above Exclusion Criteria: * Steroid therapy * Narcotic use within past 3 months * History of corticosteroid intolerance * Pregnancy * Uncontrolled diabetes * Doesn't own smart phone Drop Criteria: \- 2nd dose of IV dexamethasone
What this study is about
In the sponsor’s own words, from the registry.
This study compares the efficacy of a 5-day post-operative oral prednisone regimen (40 mg daily) with the standard intraoperative steroid regimen, focusing on pain, swelling, range of motion, opioid use, and glucose levels monitored continuously.
Study sites(1)
Columbia University Irving Medical Center
New York, New York, United States
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07630896. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me